Healthcare Global Financials
| HCG Stock | 527.70 10.65 2.06% |
Operating Margin | PE Ratio 127.4638 | Profit Margin | EPS Estimate Current Year 4.425 | EPS Estimate Current Quarter 1.81 |
Healthcare | Select Account or Indicator |
Understanding current and past Healthcare Global Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Healthcare Global's financial statements are interrelated, with each one affecting the others. For example, an increase in Healthcare Global's assets may result in an increase in income on the income statement.
Please note, the presentation of Healthcare Global's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Healthcare Global's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Healthcare Global's management manipulating its earnings.
Healthcare Global Stock Summary
Healthcare Global competes with Kingfa Science, Rico Auto, GACM Technologies, COSMO FIRST, and JNK India. Healthcare Global is entity of India. It is traded as Stock on NSE exchange.| Foreign Associate | USA |
Specialization | Health Care, Health Care Equipment & Services |
| Instrument | India Stock View All |
| Exchange | National Stock Exchange of India |
| ISIN | INE075I01017 |
| Business Address | Unity Building Complex, |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.hcgoncology.com |
| Phone | 91 80 4660 7700 |
You should never invest in Healthcare Global without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Healthcare Stock, because this is throwing your money away. Analyzing the key information contained in Healthcare Global's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Healthcare Global Key Financial Ratios
There are many critical financial ratios that Healthcare Global's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Healthcare Global reports annually and quarterly.| Revenue | 18.9 B | ||||
| Gross Profit | 11.2 B | ||||
| EBITDA | 3.5 B | ||||
| Net Income | 677.29 M | ||||
| Cash And Equivalents | 773.02 M |
Healthcare Global Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 20.4B | 22.2B | 23.2B | 27.1B | 31.1B | 17.5B | |
| Other Current Liab | 622.7M | 1.6B | 755.1M | 2.1B | 2.4B | 1.3B | |
| Net Debt | 9.5B | 7.2B | 7.3B | 10.0B | 11.5B | 6.7B | |
| Retained Earnings | (4.8B) | (4.4B) | (4.5B) | (5.0B) | (4.5B) | (4.2B) | |
| Accounts Payable | 1.5B | 1.9B | 2.5B | 2.8B | 3.2B | 1.6B | |
| Cash | 300.0M | 2.0B | 1.7B | 2.7B | 3.1B | 3.3B | |
| Other Assets | 1.5B | 1.2B | 255.3M | (20K) | (23K) | (21.9K) | |
| Net Receivables | 2.1B | 2.4B | 3.0B | 2.9B | 3.4B | 1.8B | |
| Good Will | 963.4M | 1.8B | 1.8B | 2.2B | 2.6B | 2.7B | |
| Inventory | 211.1M | 299.7M | 382.9M | 426.7M | 490.7M | 251.8M | |
| Other Current Assets | 463.3M | 283.0M | 339.2M | 400.9M | 461.0M | 269.2M | |
| Total Liab | 13.2B | 13.4B | 14.5B | 18.4B | 21.2B | 11.3B | |
| Total Current Assets | 4.3B | 5.0B | 5.8B | 6.8B | 7.8B | 8.2B | |
| Short Term Debt | 1.6B | 859.0M | 863.9M | 2.3B | 2.6B | 2.8B | |
| Intangible Assets | 214.9M | 298.0M | 186.7M | 298.7M | 343.5M | 210.0M | |
| Common Stock | 1.3B | 1.4B | 1.4B | 1.4B | 1.6B | 1.1B | |
| Other Liab | 1.2B | 408.8M | 372.9M | 614.8M | 707.0M | 695.7M | |
| Net Tangible Assets | 2.4B | 5.8B | 6.6B | 6.6B | 7.6B | 4.4B | |
| Long Term Debt | 3.5B | 3.6B | 3.6B | 4.9B | 5.6B | 3.7B | |
| Short Long Term Debt | 670.2M | 447.6M | 375.9M | 1.9B | 1.7B | 1.8B | |
| Long Term Debt Total | 11.4B | 8.2B | 8.3B | 8.1B | 9.4B | 6.5B | |
| Capital Surpluse | 5.8B | 10.0B | 11.6B | 11.6B | 13.4B | 7.6B | |
| Net Invested Capital | 11.1B | 12.8B | 12.6B | 15.0B | 17.2B | 13.0B |
Healthcare Global Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 1.1B | 838.9M | 1.0B | 994.5M | 1.1B | 686.0M | |
| Total Revenue | 10.0B | 13.8B | 16.9B | 18.9B | 21.7B | 22.8B | |
| Gross Profit | 5.0B | 7.0B | 9.1B | 9.8B | 11.3B | 11.8B | |
| Operating Income | (333.7M) | 795.5M | 1.4B | 92.8M | 106.7M | 101.4M | |
| Ebit | (1.1B) | 1.8B | 1.4B | 1.8B | 2.0B | 2.1B | |
| Ebitda | 474.5M | 3.4B | 3.1B | 3.5B | 4.0B | 4.2B | |
| Cost Of Revenue | 5.0B | 6.8B | 7.8B | 9.1B | 10.5B | 11.0B | |
| Income Before Tax | (2.3B) | 877.7M | 448.7M | 677.3M | 778.9M | 817.8M | |
| Net Income | (1.9B) | 537.3M | 293.4M | 481.6M | 553.8M | 581.5M | |
| Income Tax Expense | (75.6M) | 488.5M | 272.5M | 264.0M | 303.5M | 318.7M | |
| Minority Interest | 168.2M | 148.1M | 117.2M | 68.2M | 61.4M | 58.3M | |
| Tax Provision | (75.6M) | 488.5M | 272.5M | 264M | 303.6M | 318.8M | |
| Interest Income | 1.2B | 992.1M | 1.0B | 127.0M | 146.0M | 138.7M | |
| Net Interest Income | (1.2B) | (977.7M) | (1.0B) | (1.1B) | (978.7M) | (1.0B) |
Healthcare Global Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Healthcare Global. It measures of how well Healthcare is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Healthcare Global brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Healthcare had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Healthcare Global has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 21.5M | (60.8M) | (83.1M) | (39.5M) | (35.6M) | (37.3M) | |
| Change In Cash | 616.6M | 1.9B | (215.1M) | (51.6M) | (59.4M) | (56.4M) | |
| Free Cash Flow | 851.0M | 1.5B | 1.2B | 989.0M | 1.1B | 1.2B | |
| Depreciation | 1.6B | 1.6B | 1.6B | 1.7B | 2.0B | 1.1B | |
| Other Non Cash Items | 1.9B | (119.3M) | 883.3M | 618.4M | 711.1M | 654.9M | |
| Capital Expenditures | 354.2M | 712.3M | 1.3B | 1.9B | 2.1B | 1.5B | |
| Net Income | (2.3B) | 877.7M | 448.7M | 677.3M | 778.9M | 817.8M | |
| End Period Cash Flow | 28.7M | 1.9B | 1.7B | 1.7B | 1.9B | 2.0B | |
| Investments | (2.9B) | 3.0B | (1.3B) | (2.3B) | (2.0B) | (1.9B) | |
| Net Borrowings | 231.2M | (2.1B) | (1.8B) | (453.4M) | (408.1M) | (387.7M) | |
| Change To Netincome | 1.1B | 997.0M | 186.3M | 1.0B | 1.2B | 1.3B |
Healthcare Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Healthcare Global's current stock value. Our valuation model uses many indicators to compare Healthcare Global value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Healthcare Global competition to find correlations between indicators driving Healthcare Global's intrinsic value. More Info.Healthcare Global Enterprises is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Healthcare Global Enterprises is roughly 1.72 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Healthcare Global's earnings, one of the primary drivers of an investment's value.Healthcare Global Systematic Risk
Healthcare Global's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Healthcare Global volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Healthcare Global correlated with the market. If Beta is less than 0 Healthcare Global generally moves in the opposite direction as compared to the market. If Healthcare Global Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Healthcare Global is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Healthcare Global is generally in the same direction as the market. If Beta > 1 Healthcare Global moves generally in the same direction as, but more than the movement of the benchmark.
Healthcare Global Enterprises Total Assets Over Time
Healthcare Global Thematic Clasifications
Healthcare Global Enterprises is part of several thematic ideas from Health Management to Management. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasHealthcare Global March 28, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Healthcare Global help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Healthcare Global Enterprises. We use our internally-developed statistical techniques to arrive at the intrinsic value of Healthcare Global Enterprises based on widely used predictive technical indicators. In general, we focus on analyzing Healthcare Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Healthcare Global's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.49 | |||
| Information Ratio | 0.0145 | |||
| Maximum Drawdown | 10.63 | |||
| Value At Risk | (2.91) | |||
| Potential Upside | 4.23 |
Complementary Tools for Healthcare Stock analysis
When running Healthcare Global's price analysis, check to measure Healthcare Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthcare Global is operating at the current time. Most of Healthcare Global's value examination focuses on studying past and present price action to predict the probability of Healthcare Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Healthcare Global's price. Additionally, you may evaluate how the addition of Healthcare Global to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |